Clinical Trial Update: Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection [Phase 1, Phase 2]

View source ↗

Summary

A ongoing Phase 1/2 clinical trial evaluating the safety and efficacy of intravenous BSG005 in patients with invasive fungal infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infection

Drugs mentioned

• BSG005

Snippet

Sponsor: Biosergen AS | Conditions: Invasive Fungal Infection | Phase 1, Phase 2 | Status: RECRUITING